trending Market Intelligence /marketintelligence/en/news-insights/trending/kQVecVPvF9twH695028qyg2 content esgSubNav
In This List

Ampio to sell common stock, warrants in registered direct offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Ampio to sell common stock, warrants in registered direct offering

Ampio Pharmaceuticals Inc. agreed to sell to investors about $6.3 million of common stock and accompanying share purchase warrants at 60 cents apiece in a registered direct offering.

The warrants are exercisable for 76 cents per share, six months after issuance and have a term of five years from the issuance date.

Closing of the offering is expected to occur June 7, subject to customary closing conditions.

Ampio plans to use the net proceeds for working capital and general corporate purposes, including financing of its Ampion clinical trial.

Joseph Gunnar & Co. LLC and Fordham Financial Management Inc. are acting as placement agents for the offering.